FLASH Radiotherapy

RADIATION3 trials

Sponsors

Varian, a Siemens Healthineers Company, Jules Bordet Institute

Conditions

Basal Cell Carcinoma (BCC)Bone Metastases in the ThoraxBone MetastasisCutaneous Squamous Cell Carcinoma (CSCC)

Phase 2

Flash Radiotherapy for Skin Cancer

Not yet recruitingNCT07455331

Jules Bordet InstituteBasal Cell Carcinoma (BCC), Cutaneous Squamous Cell Carcinoma (CSCC)

Start: 2026-06-23End: 2030-12-23Target: 60Updated: 2026-05-11

Unknown Phase

Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases

CompletedNCT04592887

Varian, a Siemens Healthineers CompanyBone Metastasis

Start: 2020-11-03End: 2023-03-27Updated: 2024-07-31

FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases in the Thorax

Active, not recruitingNCT05524064

Varian, a Siemens Healthineers CompanyBone Metastases in the Thorax

Start: 2023-03-08End: 2027-05-01Target: 10Updated: 2026-08-19

Related Papers

A safety study of ultra‐high dose rate FLASH radiotherapy in the treatment of superficial skin tumors: study protocol of a phase I trial (ChiCTR2400080935)

Precision Radiation Oncology2025-04-052 citations

FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach.

2024-03-1258 citations

Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases

JAMA Oncology2022-10-23515 citations

FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases (FAST-01): Protocol for the First Prospective Feasibility Study

JMIR Research Protocols2022-10-0482 citations